Palvella TherapeuticsPVLA

13F holders, Q4 2024 (December 31)
33holders
2famous investors
$12.01avg. 13F price*

At the end of Q4 2024, 33 institutions reported holding Palvella Therapeutics Inc. (PVLA) in their 13F filings. The largest holders were Montanova Capital, LLC ($8.6M), BVF Inc. ($8.4M) and Samsara Biocapital, LLC ($8.2M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Palvella Therapeutics Inc.
CUSIP
697947109
Latest filing quarter
Q2 2026

History

Number of 13F holders

050100150200 Q4 2024: 33Q4 2024Q1 2025: 41Q1 2025Q2 2025: 65Q2 2025Q3 2025: 100Q3 2025Q4 2025: 140Q4 2025Q1 2026: 180Q1 2026Q2 2026: 196Q2 2026

Total Exit/New Position Q4 2024

InstitutionsTotal Value
New Positions34$48.4M
Exits0$0

Ownership 33 holders

Montanova Capital, LLC 0.32% New 714,463 $8.6M
BVF Inc. 0.28% New 696,555 $8.4M
Samsara Biocapital, LLC 1.12% New 679,486 $8.2M
Frazier Life Sciences Management, L.P. 0.33% New 653,892 $7.8M
Adams Street Partners LLC 4.36% New 409,666 $4.9M
Blue Owl Capital Holdings LP 0.69% New 250,062 $3.0M
Nantahala Capital Management, LLC 0.21% New 250,062 $3.0M
ADAR1 Capital Management, LLC 0.37% New 144,641 $1.7M
DAFNA Capital Management LLC 0.22% New 71,452 $857K
BML Capital Management, LLC 0.31% New 42,130 $506K
Renaissance Technologies 0.00% New 21,371 $256K
Cresset Asset Management, LLC 0.00% New 20,911 $251K
Toronto Dominion Bank 0.00% New 13,211 $180K
Geode Capital Management, LLC 0.00% New 14,270 $171K
BlackRock, Inc. 0.00% New 12,938 $155K
Deltec Asset Management LLC 0.03% New 12,500 $150K
Vanguard Group Inc. 0.00% New 11,342 $136K
Citadel Advisors 0.00% New 10,408 $125K
Acadian Asset Management LLC 0.00% New 1,549 $18K
Citigroup Inc. 0.00% New 1,108 $13K
Group One Trading LLC 0.00% New 312 $4K
UBS Group AG 0.00% New 202 $2K
Tower Research Capital LLC (TRC) 0.00% New 175 $2K
US Bancorp \de 0.00% New 138 $2K
Morgan Stanley 0.00% New 91 $1K
Barclays PLC 0.00% New 63 $756
Wells Fargo & Company 0.00% New 50 $600
JPMorgan Chase & Co. 0.00% New 26 $312
Truvestments Capital LLC 0.00% New 14 $168
Bank of America Corp. 0.00% New 12 $144
Osaic Holdings, Inc. 0.00% New 7 $84
Allworth Financial LP 0.00% New 5 $66
Jones Financial Companies LLLP 0.00% New 3 $36

"% of holder's portfolio" is PVLA's weight in each manager's 13F, not the share of Palvella Therapeutics Inc. the manager owns.